Inventor · disambiguated record
David Shames
Also filed as: SHAMES DAVID · SHAMES DAVID S · SHAMES DAVID STUART
7 granted patents·10 pending applications·217 citations·filing 2006–2025
85Inventor score
Top patents by PatentIndex Score
17 records- 0197US7709456B2Modulation of gene expression by oligomers targeted to chromosomal DNAUNIV TEXAS·Filed 2006·Granted May 4, 2010·146 cites·12 claims
- 0294US7858592B2Interfering RNAs against the promoter region of P53UNIV TEXAS·Filed 2008·Granted Dec 28, 2010·38 cites·18 claims
- 0393US8324181B2Modulation of gene expression by oligomers targeted to chromosomal DNACOREY DAVID R·Filed 2010·Granted Dec 4, 2012·24 cites·19 claims
- 0490US11300570B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2019·Granted Apr 12, 2022·3 cites·18 claims
- 0581US2025244329A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 0679US10240207B2Cancer treatment with c-met antagonists and correlation of the latter with HGF expressionGENENTECH INC·Filed 2016·Granted Mar 26, 2019·6 cites·25 claims
- 0778US2024288430A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2023·Application pending·0 cites
- 0876US2025306027A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2025·Application pending·0 cites
- 0974US11261498B2Methods for diagnosing and treating cancerGENENTECH INC·Filed 2019·Granted Mar 1, 2022·0 cites·12 claims
- 1074US2022412981A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 1165US11674962B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2018·Granted Jun 13, 2023·0 cites·16 claims
- 1259US2015086543A1Diagnotic markersGENENTECH INC·Filed 2014·Application pending·0 cites
- 1354US2017306419A1Diagnostic markersGENENTECH INC·Filed 2017·Application pending·0 cites
- 1452US2013084286A1Diagnostic markersJANUARIO THOMAS E·Filed 2012·Application pending·0 cites
- 1545US2025346957A1Methods and compositions for classifying and treating lung cancerGENENTECH INC·Filed 2025·Application pending·0 cites
- 1644US2013259867A1Diagnosis and treatments relating to her3 inhibitorsGENENTECH INC·Filed 2013·Application pending·0 cites
- 1740US2013084287A1Diagnostic markersGENENTECH INC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →